These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 11015691)

  • 1. Structural characterization of three crystalline modifications of telmisartan by single crystal and high-resolution X-ray powder diffraction.
    Dinnebier RE; Sieger P; Nar H; Shankland K; David WI
    J Pharm Sci; 2000 Nov; 89(11):1465-79. PubMed ID: 11015691
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Single crystal and powder diffraction characterization of three polymorphic forms of Acitretin.
    Malpezzi L; Magnone GA; Masciocchi N; Sironi A
    J Pharm Sci; 2005 May; 94(5):1067-78. PubMed ID: 15799018
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structure determination of enalapril maleate form II from high-resolution X-ray powder diffraction data.
    Kiang YH; Huq A; Stephens PW; Xu W
    J Pharm Sci; 2003 Sep; 92(9):1844-53. PubMed ID: 12950002
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential surface properties of commercial crystalline telmisartan samples.
    Laad P; Shete G; Modi SR; Bansal AK
    Eur J Pharm Sci; 2013 May; 49(2):109-16. PubMed ID: 23459109
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis, spectroscopic characterization and X-ray structure of [1,2a]benzimidazol-2-yl amidine.
    Hajri A; Smirani W; Abderrahim R
    Spectrochim Acta A Mol Biomol Spectrosc; 2011 Sep; 79(5):1856-9. PubMed ID: 21708483
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Crystal structure of carnidazole form II from synchrotron X-ray powder diffraction: structural comparison with form I, the hydrated form and the low energy conformations in vacuo.
    de Armas HN; Peeters OM; Blaton N; Van den Mooter G; De Ridder DJ; Schenk H
    J Pharm Sci; 2006 Oct; 95(10):2123-36. PubMed ID: 16892212
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Polymorphism of Alprazolam (Xanax): a review of its crystalline phases and identification, crystallographic characterization, and crystal structure of a new polymorph (form III).
    de Armas HN; Peeters OM; Van den Mooter G; Blaton N
    J Pharm Sci; 2007 May; 96(5):1114-30. PubMed ID: 17455340
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Solid state characterization and crystal structure from X-ray powder diffraction of two polymorphic forms of ranitidine base.
    de Armas HN; Peeters OM; Blaton N; Van Gyseghem E; Martens J; Van Haele G; Van Den Mooter G
    J Pharm Sci; 2009 Jan; 98(1):146-58. PubMed ID: 18393299
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Conformational polymorphism VI: the crystal and molecular structures of form II, form III, and form V of 4-amino-N-2-pyridinylbenzenesulfonamide (sulfapyridine).
    Bar I; Bernstein J
    J Pharm Sci; 1985 Mar; 74(3):255-63. PubMed ID: 4009431
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antitumoral, antihypertensive, antimicrobial, and antioxidant effects of an octanuclear copper(II)-telmisartan complex with an hydrophobic nanometer hole.
    Islas MS; Martínez Medina JJ; López Tévez LL; Rojo T; Lezama L; Griera Merino M; Calleros L; Cortes MA; Rodriguez Puyol M; Echeverría GA; Piro OE; Ferrer EG; Williams PA
    Inorg Chem; 2014 Jun; 53(11):5724-37. PubMed ID: 24823617
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis, structural characterization, and biological studies of new antimony(III) complexes with thiones. The influence of the solvent on the geometry of the complexes.
    Ozturk II; Hadjikakou SK; Hadjiliadis N; Kourkoumelis N; Kubicki M; Baril M; Butler IS; Balzarini J
    Inorg Chem; 2007 Oct; 46(21):8652-61. PubMed ID: 17850141
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tris(hydroxymethyl) aminomethane salt of ramipril: synthesis, structural characterization from X-ray powder diffraction and stability studies.
    Bhattacharya A; Chattopadhyay B; Chakraborty S; Roy BN; Singh GP; Godbole HM; Rananaware UB; Mukherjee AK
    J Pharm Biomed Anal; 2012 Nov; 70():280-7. PubMed ID: 22877875
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Two polymorphs of afobazole from powder diffraction data.
    Chernyshev VV; Petkune S; Actins A; Auzins R; Davlyatshin DI; Nosyrev PV; Velikodny YA
    Acta Crystallogr C; 2013 Mar; 69(Pt 3):299-302. PubMed ID: 23459360
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ROY revisited, again: the eighth solved structure.
    Tan M; Shtukenberg AG; Zhu S; Xu W; Dooryhee E; Nichols SM; Ward MD; Kahr B; Zhu Q
    Faraday Discuss; 2018 Oct; 211(0):477-491. PubMed ID: 30033458
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structural and thermal characterization of zolpidem hemitartrate hemihydrate (Form E) and its decomposition products by laboratory X-ray powder diffraction.
    Halasz I; Dinnebier RE
    J Pharm Sci; 2010 Feb; 99(2):871-8. PubMed ID: 19697390
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Crystal structure determination of the β-cyclodextrin-p-aminobenzoic acid inclusion complex from powder X-ray diffraction data.
    Guo P; Su Y; Cheng Q; Pan Q; Li H
    Carbohydr Res; 2011 May; 346(7):986-90. PubMed ID: 21440247
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Experimental design approach for the optimisation of a HPLC-fluorimetric method for the quantitation of the angiotensin II receptor antagonist telmisartan in urine.
    Torrealday N; González L; Alonso RM; Jiménez RM; Ortiz Lastra E
    J Pharm Biomed Anal; 2003 Aug; 32(4-5):847-57. PubMed ID: 12899971
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metastable beta-phase of benzophenone: independent structure determinations via X-ray powder diffraction and single crystal studies.
    Kutzke H; Klapper H; Hammond RB; Roberts KJ
    Acta Crystallogr B; 2000 Jun; 56 (Pt 3)():486-96. PubMed ID: 10877357
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thermal and X-ray powder diffraction structural characterization of two benfluorex hydrochloride polymorphs.
    Maccaroni E; Malpezzi L; Panzeri W; Masciocchi N
    J Pharm Biomed Anal; 2010 Sep; 53(1):1-6. PubMed ID: 20347245
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of amorphization method on telmisartan solubility and the tableting process.
    Lepek P; Sawicki W; Wlodarski K; Wojnarowska Z; Paluch M; Guzik L
    Eur J Pharm Biopharm; 2013 Jan; 83(1):114-21. PubMed ID: 23085331
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.